Discontinuation report TUSSIONEX
Report ID | 98368 |
Drug Identification Number | 01916971 |
Brand name | TUSSIONEX |
Common or Proper name | Tussionex |
Company Name | SANOFI-AVENTIS CANADA INC |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | HYDROCODONE PHENYLTOLOXAMINE |
Strength(s) | 5MG 10MG |
Dosage form(s) | SUSPENSION |
Route of administration | ORAL |
Packaging size | 500ml |
ATC code | R05DA |
ATC description | COUGH SUPPRESSANTS EXCL. COMB. WITH EXPECTORANTS |
Reason for discontinuation | Business reasons |
Anticipated discontinuation date | 2020-01-14 |
Actual discontinuation date | 2020-02-07 |
Remaining supply date | 2020-01-31 |
Discontinuation status | Discontinued |
Discontinuation decision reversal | No |
Information on remaining supply | |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Company contact information | email: CAINTERNET@sanofi.com Telephone: 1-800-265-7927 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2019-11-11 | English | Compare |
v2 | 2019-11-11 | French | Compare |
v3 | 2019-12-11 | English | Compare |
v4 | 2019-12-11 | French | Compare |
v5 | 2020-01-24 | English | Compare |
v6 | 2020-01-24 | French | Compare |
v7 | 2020-03-24 | English | Compare |
Showing 1 to 7 of 7